プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Yasmine M.に依頼

Tunisia

MD | Medical Writer | Systematic Reviews & Research

プロフィール概要

Medical Doctor (MD) and published medical writer with expertise in clinical research, pharmacovigilance, and evidence-based scientific communication. Author of 20+ peer-reviewed publications and reviewer for multiple journals. I specialize in systematic reviews, literature reviews, manuscript writing, and medical editing, delivering publication-ready content that meets academic and journal standards. My work focuses on accuracy, clarity, and rigorous analysis of scientific evidence. Languages: Arabic (native), French and English (advanced).

専門分野

• ★ Pharmacovigilance/Drug Safety Monitoring
• ★ Medical Writing
• ★ Proofreading & Editing
• ☆ Neuroscience
• ☆ Neuropharmacology
• ☆ Statistics
• ☆ Health Data Analysis
• ☆ Clinical Pharmacy
• ☆ Drug Development
• ☆ Preclinical Pharmacology
• ☆ Clinical Trials
• ☆ Clinical Trials Data Analysis
• ☆ Dermatology
• ☆ Oncology
• ☆ Regulatory Affairs
• ☆ Photodermatology
• ☆ Medical Content Writing
• ☆ Continuing Medical Education (CME) Materials
• ☆ Healthcare Communications
• ☆ Patient Education Materials
• ☆ Research Summaries & Abstracts
• ☆ Literature Review
• ☆ Systematic Literature Review
• ☆ Scientific Proofreading & Editing

サービス

• Writing
• Consulting

Writing Medical Writing

Consulting Healthcare Consulting

職務経験

Medical Resident

National Center of Pharmacovigilance of Tunis

1月 2021 - 12月 2024

学歴

Faculty of Medicine of Tunis

9月 2014 - 12月 2024

認定資格

• Clinical Pharmacology Specialist

  Faculty of Medicine, University of Tunis El Manar

  2月 2026 - 現在

• Doctor of Medicine (MD)

  Faculty of Medicine, University of Tunis El Manar

  1月 2025 - 現在

出版物

JOURNAL ARTICLE

Yasmine Salem Mahjoubi, Imen Hamza, Ons Charfi, Fatma Zgolli, Sarrah Kastalli, Imen Aouinti, Sihem El Aidli (2025). Ecchymosis Induced by Sertraline: A Case Report of a Rare Adverse Reaction . Current Drug Safety.

Mahjoubi Yasmine Salem, Aouinti Imen, Dahmani Israa, Zgolli Fatma, Charfi Ons, El Aidli Sihem (2025). Facial Hyperpigmentation Following Adalimumab . Current Drug Safety.

Mouna DALDOUL, Charfi Ons, Mahjoubi Yasmine Salem, Ahmed ZAIEM, Aouinti Imen, Sihem AL AIDLI (2025). Skin necrosis following dobutamine extravasation . Journal of Biomed Research.

Mahjoubi Yasmine Salem (2025). Clinical insights and research needs in atezolizumab induced neurotoxicity . Journal of Biomed Research.

Mahjoubi Yasmine Salem, Aouinti Imen, Dahmani Israam, Zgolli Fatma, Charfi Ons, El Aidli Sihem (2025). Blinding uveitis induced by secukinumab: A case-based review . Journal of Biomed Research.

Mahjoubi Yasmine Salem, Zgolli Fatma, Dahmani Israa, Kaabi Widd, Kastalli Sarrah, Aouinti Imen, El Aidli Sihem (2025). Rhabdomyolysis Following Trimethoprim-Sulfamethoxazole Therapy: A Case Report and Review of the Literature . Current Drug Safety.

Salem, Mahjoubi Yasmine, Fatma, Zgolli, Israa, Dahmani, Widd, Kaabi, Sarrah, Kastalli, Imen, Aouinti, Sihem, El Aidli (2025). Rhabdomyolysis Following Trimethoprim-Sulfamethoxazole Therapy: A Case Report and Review of the Literature . Current Drug Safety.

Salem, M.Y., Fatma, Z., Israa, D., Kaabi, W., Sarrah, K., Imen, A., Sihem, E.A.(2025). Rhabdomyolysis Following Trimethoprim-Sulfamethoxazole Therapy: A Case Report and Review of the Literature . Current Drug Safety.

Mahjoubi, Yasmine Salem, Dahmani, Israa, Zgolli, Fatma, Kaabi, Widd, Kastalli, Sarrah, Aouintin, Imen, El Aidli, Sihem (2025). Adalimumab-induced myoclonus: A potential adverse drug reaction? . Thérapie.

Mahjoubi, Y.S., Dahmani, I., Zgolli, F., Kaabi, W., Kastalli, S., Aouintin, I., El Aidli, S.(2025). Adalimumab-induced myoclonus: A potential adverse drug reaction? . Therapies. 80. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 356-358.

Salem, Mahjoubi Yasmine, Imen, Aouinti, Israam, Dahmani, Fatma, Zgolli, Ons, Charfi, Sihem, El Aidli (2025). Blinding uveitis induced by secukinumab: A case-based review . Journal of Biomed Research.

Salem, Mahjoubi Yasmine, Imen, Aouinti, Israa, Dahmani, Fatma, Zgolli, Ons, Charfi, Sihem, El Aidli (2025). Facial Hyperpigmentation Following Adalimumab . Current Drug Safety.

Salem, M.Y., Imen, A., Israa, D., Fatma, Z., Ons, C., Sihem, E.A.(2025). Facial Hyperpigmentation Following Adalimumab . Current Drug Safety. 20. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 504-508.

Mahjoubi, Yasmine Salem, Hamza, Imen, Charfi, Ons, Zgolli, Fatma, Kastalli, Sarrah, Aouinti, Imen, El Aidli, Sihem (2025). Ecchymosis Induced by Sertraline: A Case Report of a Rare Adverse Reaction . Current Drug Safety.

Salem, Mahjoubi Yasmine (2025). Drug-Induced Peripheral Neuropathy: Focus on Newer Offending Agents . Journal of Experimental Neurology.

Daldoul, Mouna, Zaiem, Ahmed, Mahjoubi, Yasmine Salem, Charfi, Ons, Lakhoua, Ghozlane, Kastalli, Sarrah, Daghfous, Riadh, Aouinti, Imen, El Aidli, Sihem (2025). Oxybutynin induced blindness in a child: Case report . Thérapie.

Daldoul, M., Zaiem, A., Mahjoubi, Y.S., Charfi, O., Lakhoua, G., Kastalli, S., Daghfous, R., Aouinti, I., El Aidli, S.(2025). Oxybutynin induced blindness in a child: Case report . Therapies. 80. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 346-348.

Salem, Mahjoubi Yasmine (2025). Clinical insights and research needs in atezolizumab induced neurotoxicity . Journal of Biomed Research.

DALDOUL, Mouna, Ons, Charfi, Salem, Mahjoubi Yasmine, ZAIEM, Ahmed, Imen, Aouinti, AIDLI, Sihem AL (2025). Skin necrosis following dobutamine extravasation . Journal of Biomed Research.

Mouna Daldoul, Ahmed Zaiem, Yasmine Salem Mahjoubi, Ons Charfi, Ghozlane Lakhoua, Sarrah Kastalli, Riadh Daghfous, Imen Aouinti, Sihem El Aidli (2024). Oxybutynin induced blindness in a child: case report . Therapies.

Yasmine Salem Mahjoubi, Imen Hamza, Ghozlane Lakhoua, Ons Charfi, Ahmed Zaiem, Sarah Kastalli, Sihem El Aidli (2024). An Uncommon Case of DRESS Syndrome Induced by Potaba With a Positive Patch Test . American Journal of Therapeutics.

Yasmine Salem Mahjoubi, Imen Hamza, Imen Aouinti, Widd Kaabi, Ghozlane Lakhoua, Ahmed Zaiem, Sihem El Aidli (2024). Hair Lightening Following Heptaminol Treatment in a Hemodialysis Patient . American Journal of Therapeutics.

Mahjoubi, Yasmine Salem, Hamza, Imen, Aouinti, Imen, Kaabi, Widd, Lakhoua, Ghozlane, Zaiem, Ahmed, El Aidli, Sihem (2024). Hair Lightening Following Heptaminol Treatment in a Hemodialysis Patient . American Journal of Therapeutics.

Salem, Mahjoubi Yasmine (2024). Atezolizumab Induced Neurotoxicity : A Systematic Review . Journal of Experimental Neurology.

Mahjoubi Yasmine Salem (2024). Atezolizumab Induced Neurotoxicity : A Systematic Review . Journal of Experimental Neurology.

Mahjoubi, Y.S., Hamza, I., Aouinti, I., Kaabi, W., Lakhoua, G., Zaiem, A., El Aidli, S.(2024). Hair Lightening Following Heptaminol Treatment in a Hemodialysis Patient . American Journal of Therapeutics. 31. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString e602-e604.

Salem Mahjoubi, Yasmine (2024). Balance Between Phenotyping and Genotyping Methods of N-Acetyltransferase 2 in Tunisia and Comparison with Other Countries: A Rapid Review . Eurasian Journal of Medical Advances.

Zaiem, A., Salem Mahjoub, Y.(2024). Response to Letter about “Chronic spontaneous urticaria after COVID-19 vaccination” . Therapies.

Zaiem, Ahmed, Salem Mahjoub, Yasmine (2024). Response to Letter about "Chronic spontaneous urticaria after COVID-19 vaccination" . Thérapie.

Mahjoubi, Y.S., Kaabi, W., Lakhoua, G., Zaiem, A., Daghfous, R., Aouinti, I., El Aidli, S.(2024). Tubulointerstitial Nephritis Induced by Adalimumab . Turkish Journal of Nephrology. 33. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 301-302.

Mahjoubi, Yasmine Salem, Kaabi, Widd, Lakhoua, Ghozlane, Zaiem, Ahmed, Daghfous, Riadh, Aouinti, Imen, El Aidli, Sihem (2024). Tubulointerstitial Nephritis Induced byAdalimumab . Turkish Journal of Nephrology.

Mahjoubi, Yasmine Salem, Dahmani, Israa, Souilem, Ines, Aouinti, Imen, Kastalli, Sarrah, Daghfous, Riadh, Aidli, Sihem El (2024). Acute angle closure glaucoma following COVID-19 vaccination . Thérapie.

Salem Mahjoubi, Y., Dahmani, I., Souilem, I., Aouinti, I., Kastalli, S., Daghfous, R., El Aidli, S.(2024). Acute angle closure glaucoma following COVID-19 vaccination . Therapies. 79. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 396-398.

Mahjoubi, Yasmine Salem, Aouinti, Imen, Charfi, Ons, Zaiem, Ahmed, Kaabi, Widd, Lakhoua, Ghozlane, Daghfous, Riadh, El Aidli, Sihem (2024). Neurotoxicity following atezolizumab in a patient with tolerated rechallenge . Thérapie.

Salem Mahjoubi, Y., Aouinti, I., Charfi, O., Zaiem, A., Kaabi, W., Lakhoua, G., Daghfous, R., El Aidli, S.(2024). Neurotoxicity following atezolizumab in a patient with tolerated rechallenge . Therapies. 79. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 393-396.

Mahjoubi, Yasmine Salem, Hamza, Imen, Lakhoua, Ghozlane, Charfi, Ons, Zaiem, Ahmed, Kastalli, Sarah, El Aidli, Sihem (2024). An Uncommon Case of DRESS Syndrome Induced by Potaba With a Positive Patch Test . American Journal of Therapeutics.

Mahjoubi, Y.S., Hamza, I., Lakhoua, G., Charfi, O., Zaiem, A., Kastalli, S., El Aidli, S.(2024). An Uncommon Case of DRESS Syndrome Induced by Potaba With a Positive Patch Test . American Journal of Therapeutics. 31. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString e600-e602.

Salem Mahjoubi Y, Dahmani I, Souilem I, Aouinti I, Kastalli S, Daghfous R, El Aidli S (2023). Acute angle closure glaucoma following COVID-19 vaccination . Therapie.

Salem Mahjoubi Y, Aouinti I, Charfi O, Zaiem A, Kaabi W, Lakhoua G, Daghfous R, El Aidli S (2023). Neurotoxicity following atezolizumab in a patient with tolerated rechallenge . Therapie.

Zaiem, Ahmed, Mahjoubi, Yasmine Salem, Aouinti, Imen, Lakhoua, Ghozlane, Kaabi, Widd, Kastalli, Sarrah, Debbiche, Sana Rebii, Charfi, Ons, El Aidli, Sihem (2023). Chronic spontaneous urticaria following vaccination against SARS-CoV-2 . Thérapie.

Zaiem, A., Salem Mahjoubi, Y., Aouinti, I., Lakhoua, G., Kaabi, W., Kastalli, S., Rebii Debbiche, S., Charfi, O., El Aidli, S.(2023). Chronic spontaneous urticaria following vaccination against SARS-CoV-2 . Therapies. 78. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 757-759.

Zaiem A, Salem Mahjoubi Y, Aouinti I, Lakhoua G, Kaabi W, Kastalli S, Rebii Debbiche S, Charfi O, El Aidli S (2022). Chronic spontaneous urticaria following vaccination against SARS-CoV-2 . Therapie.